Abstract Glucocorticosteroids are the mainstay treatment for chronic asthma; however, adverse effects can limit their usefulness. We
previously determined in experimental asthma that chronic administration of β2-adrenoceptor inverse agonists reduced airway hyperresponsiveness and indexes of inflammation. However, the effect of co-administration
of glucocorticosteroids with β2-adrenoceptor inverse agonists is unknown. Therefore, we evaluated the anti-inflammatory effect of co-administration of dexamethasone,
a glucocorticosteroid, and nadolol, a β2-inverse agonist, in a murine asthma imitation. We measured eosinophils and cytokines in bronchoalveolar lavage fluid and mucin
content in epithelial cells after exposure to different concentrations of dexamethasone and nadolol. Dexa... More information: Informations...…
Tags: